Practice parameters for diagnosing and managing iodinated contrast media hypersensitivity.

Area of Science:

• Radiology
• Allergy and Immunology
• Pharmacology

Background:

• Hypersensitivity reactions to iodinated contrast media (ICM) affect 0.5%-3% of patients.
• Current diagnostic and management guidelines for ICM hypersensitivity vary significantly.
• Controversies exist regarding optimal diagnostic and management strategies.

Purpose of the Study:

• To provide recommendations for managing patients with ICM hypersensitivity reactions.
• To analyze existing controversies in the diagnosis and management of ICM hypersensitivity.
• To offer guidance on the use of diagnostic tests and re-exposure strategies.

Main Methods:

• Review and analysis of existing guidelines and scientific literature.
• Formulation of position statements based on expert consensus.
• Emphasis on diagnostic skin testing as a primary tool.

Main Results:

• Skin tests are recommended as the initial diagnostic step for both immediate and nonimmediate ICM hypersensitivity.
• Skin tests can guide the selection of alternative contrast agents.
• Re-exposure or drug provocation tests are recommended only for ICMs that are skin test-negative.

Conclusions:

• Skin testing is crucial for diagnosing and managing ICM hypersensitivity.
• Risk-benefit analysis is essential before performing re-exposure or provocation tests.
• The utility of in vitro tests for diagnosis and prevention remains uncertain.